Literature DB >> 3731920

Comparative in vitro activity of cefpirome and other antimicrobial agents against isolates from cancer patients.

K Rolston, M E Alvarez, J F Hoy, B LeBlanc, D H Ho, G P Bodey.   

Abstract

Cefpirome and six other antimicrobial agents were tested against 884 blood culture isolates from cancer patients. Cefpirome was highly active against aerobic gram-negative bacilli including Acinetobacter spp., and the Enterobacteriaceae. Only imipenem was more active than cefpirome against Pseudomonas aeruginosa. Cefpirome was also extremely active against beta-hemolytic streptococci and methicillin-susceptible staphylococci.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3731920     DOI： 10.1159/000238433

Source DB:  PubMed          Journal:  Chemotherapy        ISSN： 0009-3157            Impact factor:   2.544


  3 in total

1.  Single agent therapy for infections in cancer patients: a prospective randomized trial comparing three extended-spectrum cephalosporins.

Authors:  K V Rolston; P G Jones; V Fainstein; N M Khardori; E J Anaissie; L Steelhammer; G P Bodey
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-03       Impact factor: 3.267

2.  Dose linearity testing of intravenous cefpirome (HR 810), a novel cephalosporin derivate.

Authors:  L Maass; V Malerczyk; M Verho; P Hajdú; K Seeger; N Klesel
Journal:  Infection       Date:  1987 May-Jun       Impact factor: 3.553

3.  Activity of cefpirome combined with beta-lactamase inhibitors and affinity for the penicillin-binding proteins of methicillin-resistant Staphylococcus aureus.

Authors:  L J Piddock; E A Traynor; D J Griggs
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-04       Impact factor: 3.267
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.